Watchful breast health,in the months between scans.
Mammography and ultrasound remain essential. But most women wait 6 to 24 months between scans. HK Biocode builds an at-home device that gently watches over that quiet gap — and prompts earlier clinical follow-up when it matters.
Class II
China NMPA medical device
211
biopsy-correlated cases (CRO: TigerMed)
2,500+
patients in multi-centre trials
9 + 11
core patents & software copyrights
Why it matters
The quiet gap between scheduled imaging
Interval cancers can develop or progress in the long months between appointments. And many women delay screening altogether — because of access, time, fear, discomfort, or a sense that the risk is low.
We asked a simple question: could a safe, non-invasive signal between screenings prompt earlier clinical follow-up?
Scheduled scan
Mammogram or ultrasound
6–24 month interval
Currently unmonitored — the quiet gap
Possible interval cancer
May develop or progress unseen
Next scheduled scan
Often months too late to act early
What Breast Guardian is
A clinically validated at-home monitoring device
01
Non-invasive
No compression, no needles, no ionising radiation — worn quietly at home.
02
Once a month
A 6+ hour wear, often overnight, fits around real life and busy schedules.
03
AI digital biomarker
A model trained against biopsy-correlated data reads a subtle thermal signal.
04
A calm, clear reading
Plain-language results — a prompt to follow up earlier, never a verdict.
And what it is not: not a replacement for mammography, ultrasound or MRI; not a biopsy; not a standalone clinical decision tool; and never a verdict of “cancer” or “no cancer.”
From wear to result
Four unhurried steps, once a month
The first month establishes a personal baseline with three readings. After that, a single reading each month is enough to keep watch.
Wear
Worn with a bandage for 6+ hours — overnight or another convenient window. No clinic visit.
Upload
The device captures a continuous temperature and humidity time-series, then syncs securely to the cloud.
Analyse
A machine-learning digital-biomarker model interprets the signal, much like reading an ambulatory Holter.
Read
An interpretable risk reading arrives in the app about 24 hours later, with clear next-step guidance.
Get in touch
Bring earlier breast-health awareness to the women you serve.
Whether you are a clinician, insurer, distribution partner, or simply want to learn more — we would be glad to talk.